Skip to main content
. 2019 Apr 26;6(6):e382–e395. doi: 10.1016/S2352-3018(19)30038-4

Figure 3.

Figure 3

HIV/AIDS care and treatment spending per year on ART (A) and prevention spending per prevalent HIV/AIDS case (B), 2016

All spending estimates are in 2018 US$. All high-income countries, as designated by the World Bank and Global Burden of Disease, were excluded (coloured in white). ART=antiretroviral therapy. ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. Isl=Islands. FSM=Federated States of Micronesia. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste.